Dividend Grudge Match: Drug Manufacturers
Match Highlights: AstraZeneca may have the higher dividend yield but the payout ratio is unsustainable,…
Abbot Laboratories: Post Spin-off Transition Still in Progress
Investment Highlights Uncertainty around the company’s spinoff transition may be holding back sentiment and provide…
A Rare Opportunity to Buy when Others are Selling
It is rare that investors get a chance to pick up good dividend-paying stocks at…
McCormick & Company: A Best of Breed with More Cash Flow Coming
Investment Highlights McCormick is the undisputed leader in its industry and one of the few…
Chubb Corporation: Wait for Weakness on this Best of Breed
Investment Highlights Chubb is a best of breed among P&C insurers for its strength in…
This Could be the Stock Market Theme of 2015
A story is quickly developing that could one of the major themes for investing in…
Dividend Reading March 2015
There have been a lot of great things happening with dividend ladder so far in…
Exxon Mobil Turns Russia into an Opportunity
Investment Highlights Exxon still faces the same challenges I pointed to last October but has…
Dover Corporation: Take Advantage of the Energy Selloff
Investment Highlights Dover uses an acquisition strategy to add businesses within its industrial focus and…
What Happens to Dividend Stocks When Rates Increase?
While the market temporarily takes its eye off of rising rates to focus on geopolitical…